22. CyberKnife M6 InCise-2 multileaf collimator setup, modelization and quality insurance program

Barbotteau, Y.; Rignon, A.; Crespin, M.; Allot, F.; Delaire, F.; Dufour, Nicolas; Michel-Amadry, G.; Moreau, D.

doi:10.1016/j.ejmp.2016.11.074

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A Robotic Intensity-Modulated Radiation Therapy (IMRT) M6 system 1,2) (Accuray, Sunnyvale, CA) with a newly released InCise TM 2 Collimator (MLC) 3) was installed at the Yonsei Cancer Center in May 2017. The InCise TM 2…”

Section: Introductionmentioning

confidence: 99%

Acceptance Testing and Commissioning of Robotic Intensity-Modulated Radiation Therapy M6 System Equipped with InCise™2 Multileaf Collimator

et al. 2018

View full text Add to dashboard Cite

This work reports the acceptance testing and commissioning experience of the Robotic IntensityModulated Radiation Therapy (IMRT) M6 system with a newly released InCise TM 2 Multileaf Collimator (MLC) installed at the Yonsei Cancer Center. Acceptance testing included a mechanical interdigitation test, leaf positional accuracy, leakage check, and End-to-End (E2E) tests. Beam data measurements included tissue-phantom ratios (TPRs), off-center ratios (OCRs), output factors collected at 11 field sizes (the smallest field size was 7.6 mm×7.7 mm and largest field size was 115.0 mm×100.1 mm at 800 mm source-to-axis distance), and open beam profiles. The beam model was verified by checking patient-specific quality assurance (QA) in four fiducial-inserted phantoms, using 10 intracranial and extracranial patient plans. All measurements for acceptance testing satisfied manufacturing specifications. Mean leaf position offsets using the Garden Fence test were found to be 0.01±0.06 mm and 0.07±0.05 mm for X1 and X2 leaf banks, respectively. Maximum and average leaf leakages were 0.20% and 0.18%, respectively. E2E tests for five tracking modes showed 0.26 mm (6D Skull), 0.3 mm (Fiducial), 0.26 mm (Xsight Spine), 0.62 mm (Xsight Lung), and 0.6 mm (Synchrony). TPRs, OCRs, output factors, and open beams measured under various conditions agreed with composite data provided from the manufacturer to within 2%. Patient-specific QA results were evaluated in two ways. Point dose measurements with an ion chamber were all within the 5% absolute-dose agreement, and relative-dose measurements using an array ion chamber detector all satisfied the 3%/3 mm gamma criterion for more than 90% of the measurement points. The Robotic IMRT M6 system equipped with the InCise TM 2 MLC was proven to be accurate and reliable.

show abstract

Section: Introductionmentioning

confidence: 99%